Introduction to SCA27B
Spinocerebellar ataxia type 27B (SCA27B) is a recently characterized, slowly progressive neurodegenerative disorder that primarily affects the cerebellar system. First linked to pathogenic expansions in the FGF14 gene, this condition is now recognized as a common cause of late-onset cerebellar ataxia. Patients often present with a complex mix of cerebellar, vestibular, and ocular motor symptoms, with dizziness and imbalance being among the earliest and most debilitating complaints.
The Genetic Basis: FGF14 Expansions
SCA27B is caused by an intronic (GAA)·(TTC) repeat expansion in the FGF14 gene, which encodes fibroblast growth factor 14. This protein is crucial for the normal function and survival of neurons, particularly in the cerebellum and other motor control regions. Normal alleles typically contain fewer than 30 repeats, whereas pathogenic expansions range from approximately 250 to over 1,000 repeats. These expanded repeats lead to reduced expression of FGF14, disrupting neuronal communication and ultimately causing degeneration.
Core Symptoms: Cerebellar and Vestibular at the Forefront
The clinical picture of SCA27B is dominated by cerebellar and vestibular dysfunction. Key symptoms include:
- Gait ataxia: A wide-based, unsteady walk that often leads to frequent falls.
- Limb ataxia: Difficulty with coordinated movements of the arms and legs.
- Dysarthria: Slurred or scanning speech due to loss of cerebellar control.
- Cerebellar oculomotor deficits: This includes downbeat nystagmus (especially in the primary position), gaze-evoked nystagmus, and impaired smooth pursuit.
- Vestibular symptoms: Prominent dizziness, vertigo, and a sensation of motion sickness. The combination of cerebellar and vestibular dysfunction creates a profound sense of imbalance.
- Episodic symptoms: Many patients experience transient episodes of vertigo and ataxia, which can initially be mistaken for Meniere’s disease or other vestibular disorders.
The Distinctive Role of Vestibular Dysfunction
Unlike many other ataxias, SCA27B frequently involves significant vestibular impairment. This is not just a subjective feeling of dizziness; objective signs include a reduced vestibular ocular reflex (VOR) gain and abnormal head impulse tests. The combination of cerebellar ataxia and bilateral vestibulopathy creates a particularly disabling form of imbalance that is resistant to simple visual or proprioceptive compensation.
Diagnosis and Management
Diagnosis of SCA27B is confirmed through genetic testing to detect the FGF14 repeat expansion. Given its recent discovery, it is likely underdiagnosed and should be considered in all patients with late-onset cerebellar ataxia, especially those with prominent vestibular symptoms and downbeat nystagmus. Management is currently symptomatic and supportive:
- Physical and vestibular therapy: Targeted exercises can help improve balance and reduce fall risk.
- Pharmacotherapy: Some patients may benefit from medications such as 4-aminopyridine to reduce downbeat nystagmus and associated dizziness.
- Lifestyle modifications: Use of walking aids and home safety adaptations are often necessary.
Conclusion
SCA27B represents a paradigm shift in our understanding of late-onset cerebellar ataxias. The strong link between FGF14 mutations and combined cerebellar-vestibular dysfunction highlights a unique pathophysiological pathway. For clinicians, recognizing the prominent role of vestibular symptoms and dizziness in this condition is key to early diagnosis. As research progresses, targeted therapies aimed at restoring FGF14 expression may one day offer disease-modifying treatment for this debilitating disorder.